Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV2024-04-22 | Chg.+24.4399 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,108.6499EUR | +1.17% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 2.31 | -1.05 | -1.18 | 1.42 | -1.89 | -5.97 | 2.68 | 12.11 | +3.96% |
| 2024 | 3.05 | 1.74 | 0.26 | -5.85 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.39% | 18.56% | 15.99% | 20.26% | 23.23% |
| Sharpe ratio | -0.44 | 1.28 | 0.06 | 0.04 | 0.20 |
| Best month | +12.11% | +12.11% | +12.11% | +12.11% | +13.15% |
| Worst month | -5.85% | -5.97% | -5.97% | -9.49% | -9.49% |
| Maximum loss | -9.49% | -9.49% | -13.26% | -20.59% | -26.96% |
| Outperformance | -3.12% | - | -0.76% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,924.4600 | +1.26% | +1.69% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 209.7800 | +4.57% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,930.2300 | -0.98% | -5.39% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,108.6499 | +4.83% | +14.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,274.5200 | +2.24% | +12.60% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 344.5200 | +2.95% | +16.46% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 309.2900 | +5.54% | +17.15% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 188.9700 | -2.63% | -6.46% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,726.2500 | +2.11% | +4.50% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 140.2600 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 561.9400 | +0.61% | -0.07% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,265.3501 | +1.14% | +1.32% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 185.2400 | -1.14% | -5.53% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 193.0300 | -0.29% | -3.21% | |
| Candriam Equities L Biotech.R US... | reinvestment | 250.2600 | +1.86% | +3.72% | |
| Candriam Equities L Biotech.C US... | reinvestment | 788.5700 | +0.97% | +1.20% | |
| Candriam Equities L Biotech.C US... | paying dividend | 724.4000 | +0.95% | +1.11% |
Performance
| YTD | -1.02% | ||
|---|---|---|---|
| 6 Months | +12.85% | ||
| 1 Year | +4.83% | ||
| 3 Years | +14.49% | ||
| 5 Years | +50.71% | ||
| Since start | +40.58% | ||
| Year | |||
| 2023 | +3.96% | ||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||
